Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Long-Term Deferred Tax (2022 - 2023)

Envoy Medical's Long-Term Deferred Tax history spans 2 years, with the latest figure at $50.2 million for Q4 2023.

  • Quarterly results put Long-Term Deferred Tax at $50.2 million for Q4 2023, up 13.08% from a year ago — trailing twelve months through Dec 2023 was $50.2 million (up 13.08% YoY), and the annual figure for FY2023 was $50.2 million, up 13.08%.
  • Long-Term Deferred Tax for Q4 2023 was $50.2 million at Envoy Medical, up from $44.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $50.2 million in Q4 2023 to a low of $44.4 million in Q4 2022.